Luboš Minář

1.4k total citations
56 papers, 687 citations indexed

About

Luboš Minář is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Luboš Minář has authored 56 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Reproductive Medicine, 21 papers in Obstetrics and Gynecology and 12 papers in Surgery. Recurrent topics in Luboš Minář's work include Ovarian cancer diagnosis and treatment (25 papers), Endometrial and Cervical Cancer Treatments (20 papers) and MicroRNA in disease regulation (8 papers). Luboš Minář is often cited by papers focused on Ovarian cancer diagnosis and treatment (25 papers), Endometrial and Cervical Cancer Treatments (20 papers) and MicroRNA in disease regulation (8 papers). Luboš Minář collaborates with scholars based in Czechia, Germany and Poland. Luboš Minář's co-authors include Vít Weinberger, Eva Jandáková, Vı́tězslav Bryja, Igor Crha, Vendula Pospíchalová, Anna Kotrbová, Aleš Hampl, Zankruti Dave, Karol Kaiser and Ladislav Ilkovics and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Theranostics.

In The Last Decade

Luboš Minář

46 papers receiving 675 citations

Peers

Luboš Minář

ONCOL

Eva Jandáková Czechia

Vít Weinberger Czechia

Xinming Yin China

Kalle Günther Germany

Mu‐Hsien Yu Taiwan

Gábor Sobel Hungary

Athanassios Dellas Switzerland

Felix Moltzahn Switzerland

Sierra A. Walker United States

Eva Jandáková Czechia

Luboš Minář

569 ×1.3

355 ×1.2

75 ×0.6

74 ×0.6

65 ×0.8

ONCOL

Citations per year, relative to Luboš Minář Luboš Minář (= 1×) peers Eva Jandáková

Countries citing papers authored by Luboš Minář

Since Specialization

Citations

This map shows the geographic impact of Luboš Minář's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luboš Minář with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luboš Minář more than expected).

Fields of papers citing papers by Luboš Minář

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luboš Minář. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luboš Minář. The network helps show where Luboš Minář may publish in the future.

Co-authorship network of co-authors of Luboš Minář

This figure shows the co-authorship network connecting the top 25 collaborators of Luboš Minář. A scholar is included among the top collaborators of Luboš Minář based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luboš Minář. Luboš Minář is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Minář, Luboš, et al.. (2025). Predictors for sentinel lymph node mapping failure using indocyanine green injection in apparent early stages of endometrial cancer: A single‐center prospective study. International Journal of Gynecology & Obstetrics. 170(3). 1214–1224.

Jandáková, Eva, et al.. (2025). Variable roles of miRNA- and apoptosis-linked genes in invasive breast cancer: expression patterns, clinicopathological associations, and prognostic significance. Molecular Biology Reports. 52(1). 703–703.

Jandáková, Eva, et al.. (2024). The Overexpressed MicroRNAs miRs-182, 155, 493, 454, and U6 snRNA and Underexpressed let-7c, miR-328, and miR-451a as Potential Biomarkers in Invasive Breast Cancer and Their Clinicopathological Significance. Oncology. 103(2). 1–16. 2 indexed citations

Jandáková, Eva, et al.. (2024). Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological parameters. Cancer Biomarkers. 40(1). 61–78. 3 indexed citations

Cibula, David, Simone Marnitz, Jaroslav Klát, et al.. (2024). Survival of patients with early-stage cervical cancer after sentinel lymph node biopsy without systematic pelvic lymphadenectomy: Primary endpoint outcome of the SENTIX prospective, single-arm, international trial (CEEGOG CX-01; ENGOT-CX2). Gynecologic Oncology. 190. S15–S15. 3 indexed citations

Jandáková, Eva, et al.. (2024). Human Endogenous Retroviruses in Breast Cancer: Altered Expression Pattern Implicates Divergent Roles in Carcinogenesis. Oncology. 102(10). 858–867. 7 indexed citations

Minář, Luboš, et al.. (2023). Therapeutical strategies for recurrent endometrial cancer. PubMed. 88(4). 302–307. 1 indexed citations

Kocián, Roman, Christhardt Koehler, Klára Benešová, et al.. (2022). 2022-RA-959-ESGO Pelvic sentinel lymph nodedistribution; the final outcome of the Sentix trial (CEEGOG-CX01; ENGOT-CX2; NCT02494063). International Journal of Gynecological Cancer. 32. A36–A36. 1 indexed citations

Rob, Lukáš, David Cibula, Paweł Knapp, et al.. (2022). Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial. Journal for ImmunoTherapy of Cancer. 10(1). e003190–e003190. 31 indexed citations

10.

Minář, Luboš, et al.. (2022). Change in the trend of surgical treatment and staging of lymph nodes in endometrial cancer – results of the Oncogynecology Center, Department of Gynecology and Obstetrics, University Hospital Brnoand Masaryk University in the years 2012–2021. PubMed. 87(5). 308–316. 1 indexed citations

11.

Minář, Luboš, et al.. (2022). Vulvar carcinoma and its recurrences – principles of surgical treatment. PubMed. 87(6). 401–407.

12.

Kotrbová, Anna, Petra Ovesná, Tomasz Radaszkiewicz, et al.. (2019). WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer. Theranostics. 10(2). 537–552. 38 indexed citations

13.

Weinberger, Vít, Markéta Bednaříková, Jitka Hausnerová, et al.. (2019). A Novel Approach to Preoperative Risk Stratification in Endometrial Cancer: The Added Value of Immunohistochemical Markers. Frontiers in Oncology. 9. 265–265. 23 indexed citations

14.

Jandáková, Eva, et al.. (2019). Ovarian Cancer: Differentially Expressed microRNAs in Tumor Tissue and Cell-Free Ascitic Fluid as Potential Novel Biomarkers. Cancer Investigation. 37(9). 440–452. 12 indexed citations

15.

Minář, Luboš, et al.. (2018). Vulvar cancer recurrence — an analysis of prognostic factors in tumour-free pathological margins patients group. Ginekologia Polska. 89(8). 425–432. 6 indexed citations

16.

Jandáková, Eva, Vít Weinberger, Luboš Minář, et al.. (2018). Ascites-Derived Extracellular microRNAs as Potential Biomarkers for Ovarian Cancer. Reproductive Sciences. 26(4). 510–522. 32 indexed citations

17.

Weinberger, Vít, Luboš Minář, Petra Ovesná, et al.. (2018). Brenner tumor of the ovary — ultrasound features and clinical management of a rare ovarian tumor mimicking ovarian cancer. Ginekologia Polska. 89(7). 357–363. 10 indexed citations

18.

Jandáková, Eva, et al.. (2017). Cell-Free Urinary MicroRNAs Expression in Small-Scale Experiments. Methods in molecular biology. 1580. 99–106. 2 indexed citations

19.

Pospíchalová, Vendula, Jan Svoboda, Zankruti Dave, et al.. (2015). Simplified protocol for flow cytometry analysis of fluorescently labeled exosomes and microvesicles using dedicated flow cytometer. Journal of Extracellular Vesicles. 4(1). 25530–25530. 309 indexed citations

20.

Jandáková, Eva, Vít Weinberger, Lenka Záveská Drábková, et al.. (2015). Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study. Pathology & Oncology Research. 21(4). 1027–1035. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact